FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2761767314> ?p ?o ?g. }

• W2761767314 endingPage "e13546" @default.
• W2761767314 startingPage "e13546" @default.
• W2761767314 abstract "e13546 Background: A key research objective in radiation oncology is to identify agents that can improve chemoradiotherapy. Nanoparticle (NP) chemotherapeutics possess several properties, such as preferential accumulation in tumors, that are uniquely suited for chemoradiotherapy. To facilitate the clinical translation of NP chemotherapeutics in chemoradiotherapy, we conducted preclinical evaluation of Genexol-PM, the only clinically approved NP chemotherapeutic with a controlled drug release profile, as a radiosensitizer using non-small cell lung cancer as a model disease. Methods: The physical characteristics and drug release profile of Genexol-PM were characterized. Genexol-PM’s efficacy as a radiosensitizer was evaluated in vitro using NSCLC cell lines and in vivousing mouse xenograft models of NSCLC. Paclitaxel dose to normal lung and liver after Genexol-PM administration were quantified and compared to that of after Taxol administration. Results: Genexol-PM have a size of 23.91 ± 0.41 nm and surface charge of -8.1 ± 3.1 mV. It releases paclitaxel in a controlled release profile. In vitro evaluation of Genexol-PM as a radiosensitizer showed it is an excellent radiosensitizer and is more effective than Taxol, its small molecule counterpart at the half maximal inhibitory concentration (IC50). In vivostudy of Genexol-PM as a radiosensitizer demonstrated that it is more effective as a radiosensitizer than Taxol. We also found that Genexol-PM leads to lower paclitaxel exposure to normal lung and liver tissue than Taxol at 6 hours post administration. Conclusions: We have demonstrated that Genexol-PM is more effective than Taxol as a radiosensitizer in the preclinical setting and holds high potential for clinical translation. Our data support the clinical evaluation of Genexol-PM in chemoradiotherapy for NSCLC." @default.
• W2761767314 created "2017-10-20" @default.
• W2761767314 creator A5001098812 @default.
• W2761767314 creator A5006031711 @default.
• W2761767314 creator A5016360316 @default.
• W2761767314 creator A5027484648 @default.
• W2761767314 creator A5037533948 @default.
• W2761767314 creator A5050942906 @default.
• W2761767314 creator A5083411426 @default.
• W2761767314 date "2013-05-20" @default.
• W2761767314 modified "2023-10-02" @default.
• W2761767314 title "Preclinical evaluation of genexol-PM, a nanoparticle formulation of paclitaxel, as a novel radiosensitizer for the treatment of non-small cell lung cancer." @default.
• W2761767314 cites W2008318438 @default.
• W2761767314 cites W2011123510 @default.
• W2761767314 cites W2028067695 @default.
• W2761767314 cites W2044202701 @default.
• W2761767314 cites W2052073718 @default.
• W2761767314 cites W2089155556 @default.
• W2761767314 cites W2091796668 @default.
• W2761767314 cites W2096593771 @default.
• W2761767314 cites W2100961085 @default.
• W2761767314 cites W2101935997 @default.
• W2761767314 cites W2105969273 @default.
• W2761767314 cites W2127410754 @default.
• W2761767314 cites W2128922346 @default.
• W2761767314 cites W2136672090 @default.
• W2761767314 cites W2143951393 @default.
• W2761767314 cites W2149984051 @default.
• W2761767314 cites W2155680971 @default.
• W2761767314 cites W2323577539 @default.
• W2761767314 doi "https://doi.org/10.1200/jco.2013.31.15_suppl.e13546" @default.
• W2761767314 hasPublicationYear "2013" @default.
• W2761767314 type Work @default.
• W2761767314 sameAs 2761767314 @default.
• W2761767314 citedByCount "1" @default.
• W2761767314 countsByYear W27617673142014 @default.
• W2761767314 crossrefType "journal-article" @default.
• W2761767314 hasAuthorship W2761767314A5001098812 @default.
• W2761767314 hasAuthorship W2761767314A5006031711 @default.
• W2761767314 hasAuthorship W2761767314A5016360316 @default.
• W2761767314 hasAuthorship W2761767314A5027484648 @default.
• W2761767314 hasAuthorship W2761767314A5037533948 @default.
• W2761767314 hasAuthorship W2761767314A5050942906 @default.
• W2761767314 hasAuthorship W2761767314A5083411426 @default.
• W2761767314 hasBestOaLocation W27617673142 @default.
• W2761767314 hasConcept C126322002 @default.
• W2761767314 hasConcept C143998085 @default.
• W2761767314 hasConcept C2776256026 @default.
• W2761767314 hasConcept C2776428644 @default.
• W2761767314 hasConcept C2776694085 @default.
• W2761767314 hasConcept C2777292972 @default.
• W2761767314 hasConcept C2778424827 @default.
• W2761767314 hasConcept C502942594 @default.
• W2761767314 hasConcept C509974204 @default.
• W2761767314 hasConcept C71924100 @default.
• W2761767314 hasConcept C98274493 @default.
• W2761767314 hasConceptScore W2761767314C126322002 @default.
• W2761767314 hasConceptScore W2761767314C143998085 @default.
• W2761767314 hasConceptScore W2761767314C2776256026 @default.
• W2761767314 hasConceptScore W2761767314C2776428644 @default.
• W2761767314 hasConceptScore W2761767314C2776694085 @default.
• W2761767314 hasConceptScore W2761767314C2777292972 @default.
• W2761767314 hasConceptScore W2761767314C2778424827 @default.
• W2761767314 hasConceptScore W2761767314C502942594 @default.
• W2761767314 hasConceptScore W2761767314C509974204 @default.
• W2761767314 hasConceptScore W2761767314C71924100 @default.
• W2761767314 hasConceptScore W2761767314C98274493 @default.
• W2761767314 hasIssue "15_suppl" @default.
• W2761767314 hasLocation W27617673141 @default.
• W2761767314 hasLocation W27617673142 @default.
• W2761767314 hasOpenAccess W2761767314 @default.
• W2761767314 hasPrimaryLocation W27617673141 @default.
• W2761767314 hasRelatedWork W2053778437 @default.
• W2761767314 hasRelatedWork W2165410491 @default.
• W2761767314 hasRelatedWork W2277416945 @default.
• W2761767314 hasRelatedWork W2357406576 @default.
• W2761767314 hasRelatedWork W2404042595 @default.
• W2761767314 hasRelatedWork W2418514417 @default.
• W2761767314 hasRelatedWork W3021135223 @default.
• W2761767314 hasRelatedWork W3029180858 @default.
• W2761767314 hasRelatedWork W4308718010 @default.
• W2761767314 hasRelatedWork W1899415052 @default.
• W2761767314 hasVolume "31" @default.
• W2761767314 isParatext "false" @default.
• W2761767314 isRetracted "false" @default.
• W2761767314 magId "2761767314" @default.
• W2761767314 workType "article" @default.